A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2004
12/09/2004	WO2004032863A3 Oral formulations for proteins and polypeptides
12/09/2004	WO2004028473A3 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
12/09/2004	WO2004024893A3 Nell-1 enhanced bone mineralization
12/09/2004	WO2004020981A3 Methods of screening cyclic peptides and identifying targets therefor
12/09/2004	WO2004017912A3 Methods for increasing the rate of heart muscle contraction
12/09/2004	WO2004011624A3 Double stranded rna structures and constructs, and methods for generating and using the same
12/09/2004	WO2004003163A3 Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis
12/09/2004	WO2003106624A3 Cancer-linked gene as target for chemotherapy
12/09/2004	WO2003093478A9 Immunoconjugates for the treatment of tumours
12/09/2004	WO2003092468A3 Biomatrix structural containment and fixation systems and methods of use thereof
12/09/2004	WO2003090687A8 Using heat shock proteins to increase immune response
12/09/2004	WO2003082898A3 Novel analogues of glucose-dependent insulinotropic polypeptide
12/09/2004	WO2003080808A3 Novel compositions and methods in cancer
12/09/2004	WO2003062262A3 Modulation of heat-shock-protein-based immunotherapies
12/09/2004	WO2003057835A3 Pak5-related compositions and methods
12/09/2004	WO2003056897A3 Highly phosphorylated acid beta-glucocerebrosidase and methods of treating gaucher's disease
12/09/2004	WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence
12/09/2004	WO2003004609A3 Novel human kielin-like proteins and polynucleotides encoding the same
12/09/2004	WO2002068591A3 G-protein coupled receptor nucleic acids, polypeptides, antibodies and uses thereof
12/09/2004	WO2002044381A8 Human vno receptor (r1)
12/09/2004	US20040250304 Novel collagen-like protein clac, precussor thereof and genes encoding the same
12/09/2004	US20040250301 Transgenic animals
12/09/2004	US20040249445 Medical device for delivering biologically active material
12/09/2004	US20040249178 Biological conjugates used for drug delivery; side effect reduction
12/09/2004	US20040249143 Hagfish cathelin-associated antimicrobial peptides and genes
12/09/2004	US20040249142 Rbp1l1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof
12/09/2004	US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss
12/09/2004	US20040249134 Factor viii c2 domain variants
12/09/2004	US20040249133 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249124 Viral protein for use in generation of immunogllobulins to prevent lymphadenopathy associated viral infections; immunotherapy; viricides
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040249122 Cationic, amphipathic beta-sheet peptides and uses thereof
12/09/2004	US20040248915 Method for administration of troxacitabine
12/09/2004	US20040248844 Method for the treatment or prevention of Flavivirus infections using nucleoside analogues
12/09/2004	US20040248842 Complexes for transporting nucleic acid into eukaryotic higher-cells
12/09/2004	US20040248840 Oligomeric compounds for the modulation of ras expression
12/09/2004	US20040248835 Administering by inhalation, injection or orally; Rna interference in vitro; genetic engineering
12/09/2004	US20040248834 Suppressors of cpg oligonucleotides and methods of use
12/09/2004	US20040248833 Therapeutic delivery compositions and methods of use thereof
12/09/2004	US20040248829 Gene expression in embryonic pancreas cells, adipocytes; prevent metabolic disorders; antidiabetic agents; obesity; eating disorders; neurodegenerative disorders
12/09/2004	US20040248828 Antisense modulation of interleukin 12 p35 subunit expression
12/09/2004	US20040248821 Administering bioflavoids with bromelin ; synergistic mixture
12/09/2004	US20040248817 Therapy for cardiovascular disorders; hypotensive agents; congestive heart failure
12/09/2004	US20040248813 Compounds and methods for the modulation of cd154
12/09/2004	US20040248810 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
12/09/2004	US20040248809 Peptides; matrix metalloproteinase related degenerative joint disease
12/09/2004	US20040248808 Methods for preventing mitochondrial permeability transition
12/09/2004	US20040248807 synthetic peptide that corresponds in amino acid sequence to the carboxyl terminal 18 amino acids in the gamma ' chain of fibrinogen
12/09/2004	US20040248805 Vascular endothelial growth factor fusion constructs and uses thereof
12/09/2004	US20040248804 Nasal administration of the LH-RH analog Leuprolide
12/09/2004	US20040248803 inhibiting Wnt mediated signaling, by inhibiting the palmitoylation of Wnt; purified in the presence of a detergent to maintain solubility; maintenance and growth of stem cells, tissue regeneration
12/09/2004	US20040248802 Poly-Glu, Tyr for neuroprotective therapy
12/09/2004	US20040248801 Multivalent ligands which carry or display at least one recognition element (RE), for binding directly or indirectly to cells or other biological particles; applicable for creating scaffolds of chemical/biological species
12/09/2004	US20040248800 Crystals and structures of epidermal growth factor receptor kinase domain
12/09/2004	US20040248799 Compositions and methods for treating cancer and hyperproliferative disorders
12/09/2004	US20040248798 Contraceptive methods and compositions related to proteasomal interference
12/09/2004	US20040248797 Pharmaceutical compositions of erythropoietin
12/09/2004	US20040248796 VEGF-B and PDGF modulation of stem cells
12/09/2004	US20040248794 Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells
12/09/2004	US20040248793 Stabilised solid compositions of factor VII polypeptides
12/09/2004	US20040248792 Thymosin alpha 1 peptide/.polymer conjugates
12/09/2004	US20040248790 eating regulator, a sleep regulator,.an arousal regulator, a pain regulator, a stress response regulator, a spontaneous behavior regulator or an emotional behavior regulator
12/09/2004	US20040248789 peptides/fusion inhibitors;
12/09/2004	US20040248788 preventing or delaying the onset by administration of growth hormone to a mammal predisposed to essential or primary hypertension; such as when subjected to intrauterine undernutrution
12/09/2004	US20040248787 fusion protein comprising a PTD (protein transduction domain) and an MITF (microphthalmia-associated transcripution factor) variant as an active ingredient with a His tag
12/09/2004	US20040248786 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/09/2004	US20040248785 mutant factor VIII has procoagulant activity; increased half-life; substituted amino acid(s) in the A2 domain
12/09/2004	US20040248784 Unitary combinations of FSH and hCG
12/09/2004	US20040248783 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
12/09/2004	US20040248782 Long lasting glucagon-like peptide2(glp-2)for the treatment of gastrointestinal diseases and disorders
12/09/2004	US20040248780 GSSP-2, GSSP-2 cDNAs and GSSP-2 polypeptides; recombinant vector; host cell
12/09/2004	US20040248778 Stable galenic freeze-dried pharmaceutical preparation of recombined carbohydrate-binding polypeptides
12/09/2004	US20040248776 Intermediates and methods for making heptapeptide oxytocin analogues
12/09/2004	US20040248774 Injectable implant of insoluble globin
12/09/2004	US20040248773 Methods for the identification of inhibitors of pyrroline-5-carboxylate reductase as antibiotics
12/09/2004	US20040248772 yeast-derived ingredient having beta 1,3/1.6 glucan structure (IMMUTOL) or Norwegian Beta Glucan (TM); natural killer cell activating capabilities and tumor angiogenesis inhibiting capability by oral administration
12/09/2004	US20040248771 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
12/09/2004	US20040248770 filtering of the antifungal agent, Caspofungin, through a zirconium-layered ceramic; reduces endotoxin levels
12/09/2004	US20040248769 hydrolytic; inhibits arginyl endopeptidase or serine protease activity; air cleaner; fabric treatment
12/09/2004	US20040248768 Nutritional composition preventing bacterial overgrowth
12/09/2004	US20040248766 Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons
12/09/2004	US20040248765 Tumour targeting prodrugs activated by metallo matrixproteinases
12/09/2004	US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004	US20040248321 Membrane protein for use in treatment and prevention of inflammatory, circulatory, cell proliferative, metabolic and immunological disorders
12/09/2004	US20040248297 Antisense modulation of phospholipase a2, group vi (ca2+independent) expression
12/09/2004	US20040248296 HIV therapeutic
12/09/2004	US20040248262 Nucleotide sequences coding lysosomal protein for use treatment of brain and muscular disorders
12/09/2004	US20040248260 IL-13 mutein proteins, antibodies, compositions, methods and uses
12/09/2004	US20040248257 Spleen expressed cell surface protein (SPLEX) for use in treatment and prevention autoimmunity, cancer, transplant rejection and inflammation
12/09/2004	US20040248256 Secreted proteins and polynucleotides encoding them
12/09/2004	US20040248255 Leukocyte stimulating peptides
12/09/2004	US20040248254 ACPL DNA and polypeptides
12/09/2004	US20040248253 Methods and compositions for polypeptide engineering
12/09/2004	US20040248251 Receptors and membrane associated proteins
12/09/2004	US20040248249 Protein for use in treatment, prevention and diagnosis of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological, and developmental disorders
12/09/2004	US20040248246 Compositions and methods for enhancing differential expression
12/09/2004	US20040248245 Zinc activated ion channel
12/09/2004	US20040248243 Lipid metabolizing polypeptide for use in identifying modulators for treatment and prevention of cancer, nervous system, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders
12/09/2004	US20040248240 Nucleotide sequences coding membrane protein for use in identifying modulator for treatment of pain management, epilepsy, stroke, ischemia and heart disease

1 ... 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 ... 3163